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ABSTRACT
This study aimed to elucidate retrospectively the correlations between the genome and phenotype 
in clinical methicillin-resistant Staphylococcus aureus (MRSA) gentamicin (GEN), clindamycin 
(CLI), and minocycline (MIN) susceptibility using next-generation sequencing (NGS) technology. 
Ninety two MRSA strains were isolated from individual inpatients treated in Hiroshima University 
Hospital, Hiroshima, Japan, extracted for their genomic DNA, and sequenced using an Illumina® 
MiSeq sequencer to obtain their de novo whole-genome assembly. An in silico analysis using 
ResFinder was performed to obtain the genomic antimicrobial susceptibility profile which was 
analyzed together with GEN, CLI, and MIN minimum inhibitory concentration (MIC) levels. 
This study found aac(6’)aph(2”)+, spc+, ermA+, tetM+ MRSA strains were predominant (42/92) 
and were shown to exhibit >16 mg/L GEN (40/42), >4 mg/L CLI (26/42), and >8 mg/L MIN MIC 
levels (30/42). Associations between aac(6’)aph(2”) detections and GEN MIC levels (p <0.001), 
ermA detections and CLI MIC levels (p <0.001), and tetM detections and MIN MIC levels (p 
<0.001) were revealed in this study. Correlations between simultaneous detections of aac(6’)
aph(2”)-spc-ermA-tetM and GEN MIC levels (φc= 0.398, p <0.001), CLI MIC levels (φc= 0.448, p 
<0.001), and MIN MIC levels (φc= 0.515, p <0.001) were revealed in this study. The genomic-
phenotypic correlation analyses in this study provided an insight of a rapid antimicrobial 
detection in MRSA using in silico genomic antimicrobial susceptibility profiling.
Key words:  Methicillin-resistant Staphylococcus aureus, next-generation sequencing, in silico 
genome analysis, antimicrobial susceptibility
Rapid antimicrobial susceptibility surveillance as 
a part of the clinical methicillin-resistant Staphylo-
coccus aureus (MRSA) infection control is required 
as previous reports have shown the rise in MRSA-
related mortalities and the increase of multi-drug 
non-susceptible strains8,15). The use of next-genera-
tion sequencing (NGS) technology would provide 
less laborious efforts, compared to the conventional 
method, for rapid antimicrobial susceptibility detec-
tion in clinical isolates by in silico susceptibility-
related genes identification17). 
Previous studies reported the use of DNA-based 
antimicrobial susceptibility genome profiling in 
clinical MRSA outbreaks1,10). These findings would 
suggest that NGS is a promising method for rapid 
antimicrobial susceptibility detection in MRSA in-
fection control. The benefit of in silico genome de-
tection of antimicrobial susceptibility would be in 
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ego, CA).
Draft de novo Genome Assembly of MRSA 
Strains
The draft de novo genome assembly was assem-
bled from the paired-end reads using SPAdes v3.5.0 
by the GABenchToB recommendations and was re-
oriented into the S. aureus N315 chromosomal se-
quence (RefSeq GCA_000009645.1) using Mauve 
v2.4.0 2,9,11,14).
In silico Genomic Antimicrobial Susceptibility 
Profile of MRSA Strains
The draft assembly sequence was aligned using 
a ResFinder v2.1 online gene-mapping tool at >90% 
identity similarity and >60% query length thresh-
olds18). This procedure aligned an assembly sequence 
into the database of acquired antimicrobial suscep-
tibility genes stored in ResFinder and reported a 
panel of those gene matches by its antimicrobial 
class. A match of an aligned assembly sequence to 
a gene at the thresholds described above was re-
ported as a positive finding. This procedure al-
lowed the identification of two genes related in 
their acquired aminoglycoside susceptibility, which 
were aac(6’)aph(2”) and spc, a gene related in the 
acquired macrolide-lincosamide-streptogramin B 
susceptibility, which was ermA, and a gene related 
in the acquired tetracycline susceptibility, which 
was tetM, from MRSA strains in this study. The 
combined gene detection pattern was then con-
structed from these genes.
Statistical Analysis
Statistical data analysis was performed using R 
v.3.3.1 aided by the R Commander v.2.2-56,13). All 
statistical analyses were performed at a significant 
value of p <0.05. The χ2 test was performed to de-
scribe the associations between individual in silico 
detection of acquired antimicrobial susceptibility 
genes and GEN, CLI, and MIN MIC levels at its 
respective non-susceptible threshold. The Fisher-
Freeman-Halton exact test of independence was 
performed and the Cramer’s V coefficient was cal-
culated to describe the correlations between the 
genomic detection patterns and the MIC levels of 
MRSA strains as observed in GEN, CLI, and MIN.
RESULTS
Minimum Inhibitory Concentration Levels 
of GEN, CLI, and MIN in MRSA Strains
Non-susceptibility to GEN was found in 75.00% 
(69/92) strains. Most of these strains (91.30%, 
63/69) were shown to exhibit >16 mg/L GEN MIC 
level. Among the GEN-susceptible strains (25%, 
23/92), most strains (82.61%, 19/23) were shown to 
exhibit ≤0.5 mg/L GEN MIC level. Non-suscepti-
bility to CLI was found in 68.48% (63/92) strains. 
Most of these strains (80.95%, 51/63) were shown 
the greater effect to the commonly administered 
antimicrobial in MRSA infections, such as genta-
micin (GEN), clindamycin (CLI), and minocycline 
(MIN)12). 
This study was designed to reveal the phenotype 
of antimicrobial susceptibility from the observation 
of MIC level, to reveal the genomic antimicrobial 
susceptibility profile identified through in silico 
analyses of draft de novo assembly, and to reveal 
the correlations between genome and phenotype of 
antimicrobial susceptibility of clinical MRSA 
strains as observed in GEN, CLI, and MIN.
METHODS
Isolation and Antimicrobial Susceptibility of 
MRSA Strains
Ninety two bacterial strains were isolated from 
the specimens of individual inpatients treated at 
Hiroshima University Hospital, Hiroshima, Japan 
during two separate time periods: October – Decem-
ber 2009 (36/92) and January 2013 – March 2014 
(56/92). Isolates were preserved in a heart infusion 
broth-10% glycerol mixture and stored at -80°C. 
Antimicrobial susceptibility was measured with an 
image analyzer (Koden IA40MIC-i, Koden, Tokyo, 
Japan) using a dry plate (Eiken, Tokyo, Japan). The 
procedure examined and reported the cefoxitin, 
GEN, CLI, and MIN MIC level according to the mod-
ified standards of the CLSI M100-S19 guideline, 
which was used in Hiroshima University Hospital, 
Hiroshima, Japan as a part of routine clinical lab-
oratory examination. All S. aureus isolates in this 
study exhibited a cefoxitin MIC of >4 mg/L and 
were classified as MRSA (data not shown). The 
GEN, CLI, and MIN MIC data were categorized 
according to the guideline described above during 
the procedure. A GEN non-susceptible strain was 
defined as a strain which exhibited ≥8 mg/L GEN 
MIC level. A CLI non-susceptible strain was de-
fined as a strain which exhibited ≥2 mg/L CLI MIC 
level. A MIN non-susceptible strain was defined as 
a strain which exhibited >8 mg/L MIN MIC level.
Extraction and Sequencing of MRSA Genomic 
DNA
A glycerol stock of each isolate was used to inoc-
ulate heart infusion agar plates (E-MC85 Pearl-
core®; Eiken, Tokyo, Japan), which were incubated 
for 12 hr at 37°C. A single colony from the plate 
was removed and cultured in blood heart infusion 
liquid medium (E-MC04; Eiken, Tokyo, Japan) us-
ing a water bath for 12 hr at 37°C. The culture 
was then centrifuged at 1600 × g for 10 min at room 
temperature to obtain a pellet. Genomic DNA was 
extracted from the pellet using a QIAamp® DNA 
Mini kit (Qiagen, Venlo, the Netherlands) and se-
quenced to obtain paired-end reads using a Nex-
tera® XT DNA kit (Illumina, San Diego, CA) and 
an Illumina® MiSeq sequencer (Illumina, San Di-
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spc-, ermA-, tetM+ and aac(6’)aph(2”)-, spc-, ermA-, 
tetM+ patterns were not found.
Individual Detection of aac(6’)aph(2”), spc, 
ermA, and tetM and Minimum Inhibitory 
Concentration Level of GEN, CLI, and MIN in 
MRSA Strains
Positive finding of aac(6’)aph(2”) was associated 
with the GEN MIC level at its non-susceptible 
threshold (Table 1), while positive findings of spc, 
ermA, and tetM were associated with the CLI (Table 
2) and MIN (Table 3) MIC levels at its non-suscep-
tible threshold. Most aac(6’)aph(2”)+ strains were 
shown to exhibit non-susceptible GEN MIC levels. 
The aac(6’)aph(2”)- strains were shown to exhibit 
either susceptible or non-susceptible GEN MIC 
levels. Most spc+ strains were shown to exhibit 
non-susceptible CLI and MIN MIC levels while 
most spc- strains were shown to exhibit susceptible 
CLI and MIN MIC levels. Similar findings of spc 
in CLI and MIN susceptibility were shown during 
the detection of ermA and tetM.
Minimum Inhibitory Concentration Level 
and Detection Pattern in GEN, CLI, and MIN 
Susceptibility in MRSA Strains 
The GEN MIC level was shown to be in a mod-
erate correlation with the detection patterns and 
the involvement of aac(6’)aph(2”) was emphasized 
to exhibit >4 mg/L CLI MIC level. Among the 
CLI-susceptible strains (31.52%, 29/92), most 
strains (93.10%, 27/29) were shown to exhibit 
≤0.12 mg/L CLI MIC level. Non-susceptibility to 
MIN was found in 40.22% (37/92) strains and all 
of these strains were shown to exhibit >8 mg/L 
MIN MIC level. Among the MIN-susceptible 
strains (59.78%, 55/92), most strains (50.90%, 
28/55) were shown to exhibit ≤1 mg/L MIN MIC 
level.
Detection Patterns of aac(6’)aph(2”), spc, 
ermA, and tetMin MRSA Strains
The MRSA in silico acquired antimicrobial sus-
ceptibility detection revealed 63.04% (58/92) strains 
were aac(6’)aph(2”)+, 77.17% (71/92) strains were 
spc+, 77.17% (71/92) strains were ermA+, and 
69.57% (64/92) strains were tetM+. All of the spc+ 
strains were ermA+ strains. From these results, 
six gene detection patterns were identified and 
consisted of aac(6’)aph(2”)+, spc+, ermA+, tetM+ as 
seen in 45.65% (42/92) strains; aac(6’)aph(2”)+, 
spc+, ermA+, tetM- as seen in 1.09% (1/92) strains; 
aac(6’)aph(2”) -, spc+, ermA+, tetM+ as seen in 
23.91% (22/92) strains; aac(6’)aph(2”)-, spc+, ermA+, 
tetM- as seen in 6.52% (6/92) strains; aac(6’)
aph(2”)+, spc-, ermA -, tetM- as seen in 16.30% 
(15/92); and aac(6’)aph(2”)-, spc-, ermA-, tetM- as 
seen in 6.52% (6/92) strains. The aac(6’)aph(2”)+, 
Table 1. Detection of aac(6’)aph(2”) revealed to be associated with the GEN MIC levels at non-susceptible threshold
Gene Detections
GEN MIC Level (mg/L)
p of S v NSS NS
≤0.5 1 4 8 16 >16
aac(6’)aph(2”) +/- 3/16 0/3 1/0 2/0 4/0 48/15 <0.001
spc +/- 15/4 3/0 0/1 0/2 0/4 53/10 0.886
ermA +/- 15/4 3/0 0/1 0/2 0/4 53/10 0.886
tetM+/- 11/8 2/1 0/1 0/2 0/4 51/12 0.116
Abbreviations: GEN, gentamicin; MIC, minimum inhibitory concentration; S, susceptible; NS, non-susceptible
Table 2. Detection of spc, ermA, and tetM revealed to be associated with the CLI MIC levels at non-susceptible threshold
Gene Detections
CLI MIC Level (mg/L)
p of S v NSS NS
≤0.12 0.25 0.5 1 2 >4
aac(6’)aph(2”) +/- 20/7 0/1 1/0 0/0 11/1 26/25 0.206
spc +/- 10/17 1/0 1/0 0/0 12/0 47/4 <0.001
ermA +/- 10/17 1/0 1/0 0/0 12/0 47/4 <0.001
tetM+/- 8/19 0/1 1/0 0/0 11/1 44/7 <0.001
Abbreviations: CLI, clindamycin; MIC, minimum inhibitory concentration; S, susceptible; NS, non-susceptible
Table 3. Detection of spc, ermA, and tetM revealed to be associated with MIN MIC levels at non-susceptible threshold
Gene Detections
MIN MIC Level (mg/L)
P of S v NSS NS
≤1 2 4 8 >8
aac(6’)aph(2”) +/- 19/9 3/3 3/5 3/10 30/7 0.522
spc +/- 10/18 6/0 8/0 12/1 35/2 <0.001
ermA +/- 10/18 6/0 8/0 12/1 35/2 <0.001
tetM+/- 3/25 6/0 8/0 12/1 35/2 <0.001
Abbreviations: MIN, minocycline; MIC, minimum inhibitory concentration; S, susceptible; NS, non-susceptible
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a strong correlation with the detection patterns 
and the involvement of tetM was emphasized (φc= 
0.515, p <0.001) (Table 6). Strains whose pattern 
included tetM, as seen in aac(6’)aph(2”)+, spc+, 
ermA+, tetM+ and aac(6’)aph(2”) -, spc+, ermA+, 
tetM+ strains, were shown to exhibit >8 mg/L MIN 
MIC level. Strains whose pattern included only 
spc-ermA, as seen in aac(6’)aph(2”)-, spc+, ermA+, 
tetM- strains, and included only aac(6’)aph(2”), as 
seen in aac(6’)aph(2”)+, spc-, ermA-, tetM- strains, 
were shown to exhibit ≤1mg/L MIN MIC levels.
Trends in Detection Patterns and GEN, CLI, 
and MIN Susceptibility between MRSA 
Strains of Two Periods
Strains which possessed an aac(6’)aph(2”)+, 
spc+, ermA+, tetM+ pattern were revealed to be in 
increasing trends between 2009 and 2013 – 2014 
and most were shown to exhibit >16 mg/L GEN 
MIC level (Fig. 1), >4 mg/L CLI MIC level (Fig. 2), 
and >8 MIN MIC level (Fig. 3). The aac(6’)aph(2”)+, 
spc+, ermA+, tetM- pattern was found only in a 2013 
– 2014 strain and was shown to exhibit >16 mg/L 
(φc= 0.398, p <0.001) (Table 4). The analysis re-
vealed strains whose detection pattern at least 
consisted of spc+ermA+ and one additional gene 
was shown to exhibit >16 mg/L GEN MIC level. 
The effect was found to be greater in the addition 
of both aac(6’)aph(2”) and tetM as seen in aac(6’)
aph(2”)+,spc+,ermA+,tetM+ strains. Singular detec-
tion of aac(6’)aph(2”) itself was found in strains 
exhibiting >16 mg/L GEN MIC level. The CLI MIC 
level was shown to be in a moderate correlation 
with the detection patterns and the involvements 
of spc and ermA were emphasized (φc= 0.448, p 
<0.001) (Table 5). The analysis revealed strains 
whose detection pattern at least consisted of 
spc+ermA+ and one additional gene shown to exhibit 
>4 mg/L CLI MIC level. The effect was found to be 
greater in the addition of tetM, as seen in aac(6’)
aph(2”)-,spc+,ermA+,tetM+, and was found to be 
greatest in the addition of both aac(6’)aph(2”) and 
tetM as seen in aac(6’)aph(2”)+,spc+,ermA+,tetM+ 
strains. Singular detection of aac(6’)aph(2”) itself 
was found in strains exhibiting ≤0.12mg/L CLI 
MIC level. The MIN MIC level was shown to be in 
Table 4. Genomic detection patterns revealed to be correlated with GEN MIC levels.
Detection Patterns
GEN MIC Level (mg/L)
Total φc p≤0.5 1 4 8 16 >16
aac(6’)aph(2”)+,spc+,ermA+,tetM+ 2 0 0 0 0 40 42
0.398 <0.001
aac(6’)aph(2”)+,spc+,ermA+,tetM- 0 0 0 0 0 1 1
aac(6’)aph(2”)-,spc+,ermA+,tetM+ 9 2 0 0 0 11 22
aac(6’)aph(2”)-,spc+,ermA+,tetM- 4 1 0 0 0 1 6
aac(6’)aph(2”)+,spc-,ermA-,tetM- 1 0 1 2 4 7 15
aac(6’)aph(2”)-,spc-,ermA-,tetM- 3 0 0 0 0 3 6
Total 19 3 1 2 4 63 92
Abbreviations: CLI, clindamycin; MIC, minimum inhibitory concentration
Table 5. Genomic detection patterns revealed to be correlated with CLI MIC levels.
Detection Patterns
CLI MIC Level (mg/L)
Total φc p≤0.12 0.25 0.5 1 2 >4
aac(6 ’)aph(2”)+,spc+,ermA+,tetM+ 5 0 1 0 10 26 42
0.448 <0.001
aac(6 ’)aph(2”)+,spc+,ermA+,tetM- 0 0 0 0 1 0 1
aac(6 ’)aph(2”)-,spc+,ermA+,tetM+ 3 0 0 0 1 18 22
aac(6 ’)aph(2”)-,spc+,ermA+,tetM- 2 1 0 0 0 3 6
aac(6 ’)aph(2”)+,spc-,ermA-,tetM- 15 0 0 0 0 0 15
aac(6 ’)aph(2”)-,spc-,ermA-,tetM- 2 0 0 0 0 4 6
Total 27 1 1 0 12 51 92
Abbreviations: CLI, clindamycin; MIC, minimum inhibitory concentration
Table 6. Genomic detection patterns revealed to be correlated with MIN MIC levels.
Detection Patterns
MIN MIC Level (mg/L)
Total φc p≤1 2 4 8 >8
aac(6 ’)aph(2”)+,spc+,ermA+,tetM+ 3 3 3 3 30 42
0.515 <0.001
aac(6 ’)aph(2”)+,spc+,ermA+,tetM- 1 0 0 0 0 1
aac(6 ’)aph(2”)-,spc+,ermA+,tetM+ 0 3 5 9 5 22
aac(6 ’)aph(2”)-,spc+,ermA+,tetM- 6 0 0 0 0 6
aac(6 ’)aph(2”)+,spc-,ermA-,tetM- 15 0 0 0 0 15
aac(6 ’)aph(2”)-,spc-,ermA-,tetM- 3 0 0 1 2 6
Total 28 6 8 13 37 92
Abbreviations: MIN, minocycline; MIC, minimum inhibitory concentration
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trends of GEN MIC levels (Fig. 1), CLI MIC levels 
(Fig. 2), and MIN MIC levels (Fig. 3) among those 
strains. The detection of aac(6’)aph(2”)-,spc+,ermA+, 
tetM- strains between two periods was found to be 
in increasing trends and was accompanied by in-
GEN MIC level (Fig. 1), 2 mg/L CLI MIC level 
(Fig. 2), and ≤1 mg/L MIN MIC level (Fig. 3). The 
detection of aac(6’)aph(2”) -, spc+, ermA+, tetM+ 
strains between two periods was shown to be in de-
creasing trends and was accompanied by decreasing 
GEN MIC 
(mg/L) 
aac(6’)aph(2”)+,spc+,ermA+,tetM+ 
‘09 
‘13/14 
‘09 
‘09 
‘09 
‘09 
‘13/14 
‘13/14 
‘13/14 
‘13/14 
‘13/14 aac(6’)aph(2”)+,spc+,ermA+,tetM- 
aac(6’)aph(2”)-,spc+,ermA+,tetM+ 
aac(6’)aph(2”)-,spc+,ermA+,tetM- 
aac(6’)aph(2”)+,spc-,ermA-,tetM- 
aac(6’)aph(2”)-,spc-,ermA-,tetM- 
Number of Strains 
Detection Pattern 
 
CLI MIC 
(mg/L) 
aac(6’)aph(2”)+,spc+,ermA+,tetM+ 
‘09 
‘13/14 
‘09 
‘09 
‘09 
‘09 
‘13/14 
‘13/14 
‘13/14 
‘13/14 
‘13/14 aac(6’)aph(2”)+,spc+,ermA+,tetM- 
aac(6’)aph(2”)-,spc+,ermA+,tetM+ 
aac(6’)aph(2”)-,spc+,ermA+,tetM- 
aac(6’)aph(2”)+,spc-,ermA-,tetM- 
aac(6’)aph(2”)-,spc-,ermA-,tetM- 
Number of Strains 
Detection Pattern 
Fig. 1. Genomic detection patterns and GEN MIC level distributions between strains isolated from 2009 and 2013 - 2014
Fig. 2. Genomic detection patterns and CLI MIC level distributions between strains isolated from 2009 and 2013 - 2014
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warrant rapid antimicrobial susceptibility detection 
provided by the in silico combined detection of 
aac(6’)aph(2”)-spc-ermA-tetM.
The use of ResFinder as described in this study 
allowed investigation of multiple acquired antimi-
crobial susceptibility genes at the same time. The 
tool also allowed detection of point mutations and/
or deletions along with the wild type sequence of 
each gene. This study found three aac(6’)aph(2’’)+ 
strains with 157C>T mutation and six aac(6’)
aph(2’’)+ strains with deletion, and all of these 
strains exhibited more than 8 mg/L GEN MIC level. 
A single detection of spc+ strain with 267G>C mu-
tation was shown to exhibit >16 mg/L GEN MIC 
level, >4 mg/L CLI MIC level, and >8 mg/L MIN 
MIC level. Twelve tetM+ strains with simultaneous 
1040G>A and 1636A>G mutations were found to 
exhibit more than 4 mg/L MIN MIC level except 
in one strain which exhibited 2 mg/L MIN MIC 
level, suggesting tetM variations or polymor-
phisms. Two ermA+ strains with 202T>C mutation 
exhibiting less than 0.5 mg/L CLI MIC levels were 
found, suggesting a mutation which could cause 
disruption in the gene function (data not shown).
A previous study used NGS technology tech-
niques and reported the association between the 
detection of antimicrobial genes and MIC level in 
GEN and CLI susceptibility at a greater number 
of MRSA isolates. The study revealed an associa-
tion between ermA and tetracycline MIC level, 
however, the association between GEN-related 
genes and GEN MIC level was not firmly estab-
creasing trends of GEN MIC levels (Fig. 1) and 
CLI MIC levels (Fig. 2) among those strains. The 
MIN MIC levels of these strains were shown to be 
steady at ≤1 mg/L between two periods (Fig. 3). 
The aac(6’)aph(2”)+, spc-, ermA-, tetM- strains which 
exhibited 16 mg/L and >16 mg/L GEN MIC level 
were found to be in increasing trends (Fig. 1). The 
CLI MIC levels (Fig. 2) and MIN MIC levels (Fig. 
3) of these strains were shown to be steady at 
≤0.12 mg/L and ≤1 mg/L, respectively, between 
two periods. The GEN MIC level of aac(6’)aph(2”)-, 
spc-, ermA-, tetM- strains between two periods was 
found to be in increasing trends (Fig. 1), while 
CLI (Fig. 2) and MIN MIC levels (Fig. 3) of these 
strains were found to be in decreasing trends.
DISCUSSION
This study demonstrated the use of NGS technol-
ogy techniques in obtaining the genomic antimicro-
bial susceptibility profile and showed the correlation 
of the genomic antimicrobial susceptibility profile 
to the MIC levels in MRSA strains. The genomic 
antimicrobial profiling performed in this study re-
vealed the co-existence of acquired genes in GEN, 
CLI, and MIN susceptibility in most MRSA strains 
which exhibited high GEN, CLI, and MIN MIC 
levels, of which aac(6’)aph(2”)+, spc+, ermA+, tetM+ 
MRSA strains were shown to be in increasing 
trends. This important finding would suggest that 
the emergence of multidrug non-susceptibility 
strains among the clinical MRSA strains would 
MIN MIC 
(mg/L) 
aac(6’)aph(2”)+,spc+,ermA+,tetM+ 
‘09 
‘13/14 
‘09 
‘09 
‘09 
‘09 
‘13/14 
‘13/14 
‘13/14 
‘13/14 
‘13/14 aac(6’)aph(2”)+,spc+,ermA+,tetM- 
aac(6’)aph(2”)-,spc+,ermA+,tetM+ 
aac(6’)aph(2”)-,spc+,ermA+,tetM- 
aac(6’)aph(2”)+,spc-,ermA-,tetM- 
aac(6’)aph(2”)-,spc-,ermA-,tetM- 
Number of Strains 
Detection Pattern 
Fig. 3. Genomic detection patterns and MIN MIC level distributions between strains isolated from 2009 and 2013 - 2014
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is a result of a complex mechanism which may 
also involve molecules remotely located from the 
detected gene itself. These conditions would limit 
the availability of the antimicrobial genes within 
the database. Discrepancy could also be reduced by 
single observations of MIC level between appropri-
ate antimicrobial class and its respective suscepti-
bility genes, instead of combined simultaneous 
detection of antimicrobial susceptibility genes. 
Combined use of NGS technology based techniques 
and other methods would effectively provide accu-
rate and reliable information, as laboratory methods 
used to detect antimicrobial susceptibility in MRSA 
should have high sensitivity and specificity. Nev-
ertheless, this study showed a promising method 
of in silico detection of antimicrobial susceptibility 
using NGS data in MRSA strains.
In conclusion, the in silico detection of aac(6’)
aph(2”)-spc-ermA-tetM would provide an insight of 
a rapid antimicrobial susceptibility detection in 
MRSA infection control during the era of multi-
drug non-susceptible MRSA strains.
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